SCHEMBL14747904

SCHEMBL14747904

Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C2CC2)n1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDK7 P50613 13/20 0.67
CDK9 P50750 12/20 0.67
BCL6 P41182 1/20 0.51
ALK Q9UM73 4/20 0.51
MET P08581 1/20 0.51
INSR P06213 1/20 0.46
AURKA O14965 1/20 0.45
NTRK1 P04629 1/20 0.45
IGF1R P08069 1/20 0.45
CDK4 P11802 1/20 0.45
EPHA1 P21709 1/20 0.45
CDK2 P24941 1/20 0.45
CDK3 Q00526 1/20 0.45
CDK6 Q00534 1/20 0.45
CDK5 Q00535 1/20 0.45
PTK2 Q05397 1/20 0.43
AXL P30530 1/20 0.43
NEK2 P51955 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24716910 0.88 CDK7 (0.67) CDK7CDK9ALKMETINSR
SCHEMBL12312014 0.84 CDK7 (0.71) CDK7CDK9ALKMETINSR
SCHEMBL12312023 0.80 CDK7 (0.66) CDK7CDK9ALKMETINSR
SCHEMBL12862540 0.80 CDK7 (0.66) CDK7CDK9ALKMETINSR
Hydrochloric Acid SCHEMBL30817651 0.79 CDK7 (0.64) CDK7CDK9ALKMETINSR
SCHEMBL12862529 0.78 ZAP70 (0.51) CDK7CDK9BCL6ALKMET
SCHEMBL31251230 0.76 CDK7 (0.53) CDK7CDK9ALKMETIGF1R
SCHEMBL29214356 0.76 CDK7 (0.76) CDK7CDK9ALKMETAURKA
SCHEMBL29214353 0.76 CDK7 (0.76) CDK7CDK9ALKMETAURKA
SCHEMBL20232208 0.72 BCL6 (0.58) CDK9BCL6ALKAURKAIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2275413-B1 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders NOVARTIS AG (CH) 2013-03-06 EP disclosed